Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Gene duplication and deletion, not horizontal transfer, drove intra-species mosaicism of Bartonella henselae.

Banerjee R, Shine O, Rajachandran V, Krishnadas G, Minnick MF, Paul S, Chattopadhyay S.

Genomics. 2019 Mar 19. pii: S0888-7543(18)30730-4. doi: 10.1016/j.ygeno.2019.03.009. [Epub ahead of print]

PMID:
30902757
2.

Identification of novel MITEs (miniature inverted-repeat transposable elements) in Coxiella burnetii: implications for protein and small RNA evolution.

Wachter S, Raghavan R, Wachter J, Minnick MF.

BMC Genomics. 2018 Apr 11;19(1):247. doi: 10.1186/s12864-018-4608-y.

3.

Analysis of the Caenorhabditis elegans innate immune response to Coxiella burnetii.

Battisti JM, Watson LA, Naung MT, Drobish AM, Voronina E, Minnick MF.

Innate Immun. 2017 Feb;23(2):111-127. doi: 10.1177/1753425916679255. Epub 2016 Nov 24.

4.

The Intervening Sequence of Coxiella burnetii: Characterization and Evolution.

Warrier I, Walter MC, Frangoulidis D, Raghavan R, Hicks LD, Minnick MF.

Front Cell Infect Microbiol. 2016 Aug 19;6:83. doi: 10.3389/fcimb.2016.00083. eCollection 2016.

5.

Mutation-Driven Divergence and Convergence Indicate Adaptive Evolution of the Intracellular Human-Restricted Pathogen, Bartonella bacilliformis.

Paul S, Minnick MF, Chattopadhyay S.

PLoS Negl Trop Dis. 2016 May 11;10(5):e0004712. doi: 10.1371/journal.pntd.0004712. eCollection 2016 May.

6.

Colonization of Lutzomyia verrucarum and Lutzomyia longipalpis Sand Flies (Diptera: Psychodidae) by Bartonella bacilliformis, the Etiologic Agent of Carrión's Disease.

Battisti JM, Lawyer PG, Minnick MF.

PLoS Negl Trop Dis. 2015 Oct 5;9(10):e0004128. doi: 10.1371/journal.pntd.0004128. eCollection 2015.

7.

Proteins of Bartonella bacilliformis: Candidates for Vaccine Development.

Henriquez-Camacho C, Ventosilla P, Minnick MF, Ruiz J, Maguiña C.

Int J Pept. 2015;2015:702784. doi: 10.1155/2015/702784. Epub 2015 Aug 30. Review.

8.

Oroya fever and verruga peruana: bartonelloses unique to South America.

Minnick MF, Anderson BE, Lima A, Battisti JM, Lawyer PG, Birtles RJ.

PLoS Negl Trop Dis. 2014 Jul 17;8(7):e2919. doi: 10.1371/journal.pntd.0002919. eCollection 2014 Jul. Review.

9.

Identification of novel small RNAs and characterization of the 6S RNA of Coxiella burnetii.

Warrier I, Hicks LD, Battisti JM, Raghavan R, Minnick MF.

PLoS One. 2014 Jun 20;9(6):e100147. doi: 10.1371/journal.pone.0100147. eCollection 2014.

10.

Sequestration and scavenging of iron in infection.

Parrow NL, Fleming RE, Minnick MF.

Infect Immun. 2013 Oct;81(10):3503-14. doi: 10.1128/IAI.00602-13. Epub 2013 Jul 8.

11.

Kinetic models reveal the in vivo mechanisms of mutagenesis in microbes and man.

Wright BE, Schmidt KH, Minnick MF.

Mutat Res. 2013 Apr-Jun;752(2):129-37. doi: 10.1016/j.mrrev.2012.12.003. Epub 2012 Dec 26. Review.

12.

Developmental biology of Coxiella burnetii.

Minnick MF, Raghavan R.

Adv Exp Med Biol. 2012;984:231-48. doi: 10.1007/978-94-007-4315-1_12. Review.

PMID:
22711635
13.

Genetics of Coxiella burnetii: on the path of specialization.

Minnick MF, Raghavan R.

Future Microbiol. 2011 Nov;6(11):1297-314. doi: 10.2217/fmb.11.116. Review.

14.

Evolution of coordinated mutagenesis and somatic hypermutation in VH5.

Wright BE, Schmidt KH, Hunt AT, Reschke DK, Minnick MF.

Mol Immunol. 2011 Dec;49(3):537-48. doi: 10.1016/j.molimm.2011.10.001. Epub 2011 Nov 5.

15.

Ribozyme stability, exon skipping, and a potential role for RNA helicase in group I intron splicing by Coxiella burnetii.

Hicks LD, Warrier I, Raghavan R, Minnick MF.

J Bacteriol. 2011 Oct;193(19):5292-9. doi: 10.1128/JB.05472-11. Epub 2011 Jul 29.

16.

The roles of transcription and genotoxins underlying p53 mutagenesis in vivo.

Wright BE, Schmidt KH, Hunt AT, Lodmell JS, Minnick MF, Reschke DK.

Carcinogenesis. 2011 Oct;32(10):1559-67. doi: 10.1093/carcin/bgr177. Epub 2011 Jul 29.

17.

A unique Coxiella burnetii lipoprotein involved in metal binding (LimB).

Battisti JM, Hicks LD, Minnick MF.

Microbiology. 2011 Apr;157(Pt 4):966-76. doi: 10.1099/mic.0.046649-0. Epub 2011 Jan 6.

18.

Pentamidine inhibits Coxiella burnetii growth and 23S rRNA intron splicing in vitro.

Minnick MF, Hicks LD, Battisti JM, Raghavan R.

Int J Antimicrob Agents. 2010 Oct;36(4):380-2. doi: 10.1016/j.ijantimicag.2010.05.017.

19.

A DNA-binding peroxiredoxin of Coxiella burnetii is involved in countering oxidative stress during exponential-phase growth.

Hicks LD, Raghavan R, Battisti JM, Minnick MF.

J Bacteriol. 2010 Apr;192(8):2077-84. doi: 10.1128/JB.01324-09. Epub 2010 Feb 19.

20.

Group I introns and inteins: disparate origins but convergent parasitic strategies.

Raghavan R, Minnick MF.

J Bacteriol. 2009 Oct;191(20):6193-202. doi: 10.1128/JB.00675-09. Epub 2009 Aug 7. Review. No abstract available.

21.

Pestilence, persistence and pathogenicity: infection strategies of Bartonella.

Minnick MF, Battisti JM.

Future Microbiol. 2009 Aug;4(6):743-58. doi: 10.2217/fmb.09.41. Review.

22.

A unique group I intron in Coxiella burnetii is a natural splice mutant.

Raghavan R, Hicks LD, Minnick MF.

J Bacteriol. 2009 Jun;191(12):4044-6. doi: 10.1128/JB.00359-09. Epub 2009 Apr 17.

23.

Function, regulation, and transcriptional organization of the hemin utilization locus of Bartonella quintana.

Parrow NL, Abbott J, Lockwood AR, Battisti JM, Minnick MF.

Infect Immun. 2009 Jan;77(1):307-16. doi: 10.1128/IAI.01194-08. Epub 2008 Nov 3.

24.

Laboratory maintenance of Bartonella quintana.

Battisti JM, Minnick MF.

Curr Protoc Microbiol. 2008 Aug;Chapter 3:Unit 3C.1.1-3C.1.13. doi: 10.1002/9780471729259.mc03c01s10.

PMID:
18729057
25.

Toxic introns and parasitic intein in Coxiella burnetii: legacies of a promiscuous past.

Raghavan R, Hicks LD, Minnick MF.

J Bacteriol. 2008 Sep;190(17):5934-43. doi: 10.1128/JB.00602-08. Epub 2008 Jul 7.

26.

I. VH gene transcription creates stabilized secondary structures for coordinated mutagenesis during somatic hypermutation.

Wright BE, Schmidt KH, Minnick MF, Davis N.

Mol Immunol. 2008 Aug;45(13):3589-99. doi: 10.1016/j.molimm.2008.02.030. Epub 2008 Jun 27.

27.

II. Correlations between secondary structure stability and mutation frequency during somatic hypermutation.

Wright BE, Schmidt KH, Davis N, Hunt AT, Minnick MF.

Mol Immunol. 2008 Aug;45(13):3600-8. doi: 10.1016/j.molimm.2008.05.012. Epub 2008 Jun 26.

28.
29.

Transcriptional regulation of the heme binding protein gene family of Bartonella quintana is accomplished by a novel promoter element and iron response regulator.

Battisti JM, Smitherman LS, Sappington KN, Parrow NL, Raghavan R, Minnick MF.

Infect Immun. 2007 Sep;75(9):4373-85. Epub 2007 Jun 18.

30.

Proteomic and immunoblot analyses of Bartonella quintana total membrane proteins identify antigens recognized by sera from infected patients.

Boonjakuakul JK, Gerns HL, Chen YT, Hicks LD, Minnick MF, Dixon SE, Hall SC, Koehler JE.

Infect Immun. 2007 May;75(5):2548-61. Epub 2007 Feb 16.

31.

Environmental signals generate a differential and coordinated expression of the heme receptor gene family of Bartonella quintana.

Battisti JM, Sappington KN, Smitherman LS, Parrow NL, Minnick MF.

Infect Immun. 2006 Jun;74(6):3251-61.

32.
33.

Characterization and expression analysis of the groESL operon of Bartonella bacilliformis.

Callison JA, Battisti JM, Sappington KN, Smitherman LS, Minnick MF.

Gene. 2005 Oct 10;359:53-62.

34.

Mechanisms by which transcription can regulate somatic hypermutation.

Wright BE, Schmidt KH, Minnick MF.

Genes Immun. 2004 May;5(3):176-82.

PMID:
14985674
35.

Mitogenic effect of Bartonella bacilliformis on human vascular endothelial cells and involvement of GroEL.

Minnick MF, Smitherman LS, Samuels DS.

Infect Immun. 2003 Dec;71(12):6933-42.

37.

Five-member gene family of Bartonella quintana.

Minnick MF, Sappington KN, Smitherman LS, Andersson SG, Karlberg O, Carroll JA.

Infect Immun. 2003 Feb;71(2):814-21.

38.

gyrA mutations in ciprofloxacin-resistant Bartonella bacilliformis strains obtained in vitro.

Minnick MF, Wilson ZR, Smitherman LS, Samuels DS.

Antimicrob Agents Chemother. 2003 Jan;47(1):383-6.

40.

Experimental model of human body louse infection using green fluorescent protein-expressing Bartonella quintana.

Fournier PE, Minnick MF, Lepidi H, Salvo E, Raoult D.

Infect Immun. 2001 Mar;69(3):1876-9.

41.

Hemin-binding surface protein from Bartonella quintana.

Carroll JA, Coleman SA, Smitherman LS, Minnick MF.

Infect Immun. 2000 Dec;68(12):6750-7.

42.

Bartonella interactions with host cells.

Minnick MF, Anderson BE.

Subcell Biochem. 2000;33:97-123. Review. No abstract available.

PMID:
10804853
43.

A bacteriophage-like particle from Bartonella bacilliformis.

Barbian KD, Minnick MF.

Microbiology. 2000 Mar;146 ( Pt 3):599-609.

PMID:
10746763
44.

Development of a system for genetic manipulation of Bartonella bacilliformis.

Battisti JM, Minnick MF.

Appl Environ Microbiol. 1999 Aug;65(8):3441-8.

45.
46.

Mutations in Bartonella bacilliformis gyrB confer resistance to coumermycin A1.

Battisti JM, Smitherman LS, Samuels DS, Minnick MF.

Antimicrob Agents Chemother. 1998 Nov;42(11):2906-13.

47.
48.
49.
50.

Cell entry and the pathogenesis of Bartonella infections.

Minnick MF, Mitchell SJ, McAllister SJ.

Trends Microbiol. 1996 Sep;4(9):343-7. Review.

PMID:
8885168

Supplemental Content

Loading ...
Support Center